2'-fluorothymidine has been researched along with Hepatitis B Virus Infection in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JY; Kim, NH; Koh, MS; Lee, JH; Park, KS; Park, SH | 1 |
| Kim, HS; Park, SA; Shin, YI; Yang, CY | 1 |
| Shouval, D | 1 |
| Byun, KS; Cho, M; Cho, SH; Chon, CY; Chung, YH; Han, BH; Han, CJ; Han, JY; Hwang, JS; Hwang, SG; Kim, BI; Kim, HC; Kim, JH; Kim, TH; Kim, YS; Koh, KC; Lee, HJ; Lee, HS; Lee, KS; Lee, MS; Lee, YS; Paik, SW; Ryu, SH; Um, SH; Yang, JM; Yoo, BC; Yoo, HW; Yoo, K | 1 |
| Abdelhamed, AM; Furman, PA; Isom, HC; Kelley, CM; Miller, TG | 1 |
| Chevallier, M; Guerret, S; Jacquard, AC; Jamard, C; Nassal, M; Peyrol, S; Pichoud, C; Ren, S; Rimsky, LT; Schultz, U; Trepo, C; Werle, B; Zoulim, F | 1 |
| Buti, M; Esteban, R | 1 |
| Kang, MJ; Kim, DH; Lee, HS; Lee, J; Yoo, BC; Yoo, HH; Yoo, HW | 1 |
| Byun, KS; Cho, M; Cho, SH; Choi, JY; Choi, SK; Chon, CY; Chung, YH; Han, BH; Han, JY; Hwang, JS; Hwang, SG; Jeong, SH; Kim, BI; Kim, DG; Kim, HC; Kim, JH; Kim, TH; Kim, YS; Kweon, YO; Lee, HJ; Lee, HS; Lee, HY; Lee, KS; Lee, MS; Lee, YJ; Lee, YS; Paik, SW; Park, JW; Ryu, SH; Um, SH; Yang, JM; Yoo, BC; Yoo, HW; Yoo, K | 1 |
| Kocic, I | 1 |
| Boyer, N; Castelneau, C; Marcellin, P | 1 |
3 review(s) available for 2'-fluorothymidine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Drugs in development for hepatitis B.
Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; Emtricitabine; Guanine; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Nucleosides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir | 2005 |
Clevudine University of Georgia/Abbott/Bukwang/Triangle/Yale University.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Contraindications; Drugs, Investigational; Epstein-Barr Virus Infections; Hepatitis B; Humans; Structure-Activity Relationship | 2000 |
[New management strategies for hepatitis B].
Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; Emtricitabine; Guanine; Hepatitis B; Humans; Lamivudine; Organophosphonates | 2002 |
2 trial(s) available for 2'-fluorothymidine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Rapid quantitative determination of L-FMAU-TP from human peripheral-blood mononuclear cells of hepatitis B virus-infected patients treated with L-FMAU by ion-pairing, reverse-phase, liquid chromatography/electrospray tandem mass spectrometry.
Topics: Adult; Antiviral Agents; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Half-Life; Hepatitis B; Humans; Mass Spectrometry; Middle Aged; Reproducibility of Results | 2006 |
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B.
Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; Double-Blind Method; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Male; Middle Aged; Placebos | 2007 |
6 other study(ies) available for 2'-fluorothymidine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Clevudine Induced Mitochondrial Myopathy.
Topics: Adult; Aged; Antiviral Agents; Arabinofuranosyluracil; Creatine Kinase; Databases, Factual; Electromyography; Female; Hepatitis B; Humans; L-Lactate Dehydrogenase; Lower Extremity; Male; Middle Aged; Mitochondrial Myopathies; Muscle, Skeletal; Neck | 2017 |
Polymyositis in patients taking antiviral clevudine therapy: a report of two cases.
Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; Creatine Kinase; Female; Hepatitis B; Humans; Male; Middle Aged; Polymyositis | 2010 |
Focus.
Topics: Albumins; Antiviral Agents; Arabinofuranosyluracil; Cholangitis, Sclerosing; Cholestasis; Dialysis Solutions; Gastrointestinal Neoplasms; Hepatitis B; Humans; Incidence; Muscular Diseases; Pruritus; Renal Dialysis; Risk Factors | 2010 |
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy.
Topics: Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Viral Load | 2011 |
Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment.
Topics: Antiviral Agents; Arabinofuranosyluracil; Baculoviridae; Cell Line; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Kinetics; Lamivudine; Recombination, Genetic; Virus Replication | 2002 |
Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
Topics: Adenoviridae; Animals; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; DNA-Directed DNA Polymerase; Drug Combinations; Emtricitabine; Genetic Therapy; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Virus, Woodchuck; Interferon-gamma; Liver; Marmota; Microscopy, Confocal; Microscopy, Electron; Mitochondria, Liver; Proliferating Cell Nuclear Antigen; Recombinant Proteins; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Viremia; Virus Replication | 2004 |